GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 256 filers reported holding GW PHARMACEUTICALS PLC in Q2 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,978,000 | -19.8% | 20,319 | +1.1% | 0.05% | -25.4% |
| Q2 2020 | $2,466,000 | +54.6% | 20,093 | +10.3% | 0.07% | +14.5% |
| Q1 2020 | $1,595,000 | -15.2% | 18,211 | +1.2% | 0.06% | +100.0% |
| Q4 2019 | $1,882,000 | +36.4% | 18,000 | +50.0% | 0.03% | +10.7% |
| Q3 2019 | $1,380,000 | -33.3% | 12,000 | 0.0% | 0.03% | -49.1% |
| Q2 2019 | $2,069,000 | -38.6% | 12,000 | -40.0% | 0.06% | -34.5% |
| Q1 2019 | $3,371,000 | +44.2% | 20,000 | -16.7% | 0.08% | -13.4% |
| Q4 2018 | $2,337,000 | +8.2% | 24,000 | +92.0% | 0.10% | +70.2% |
| Q3 2018 | $2,159,000 | -12.7% | 12,500 | -29.5% | 0.06% | -3.4% |
| Q2 2018 | $2,474,000 | +9.8% | 17,733 | -11.3% | 0.06% | -16.9% |
| Q1 2018 | $2,253,000 | – | 20,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |